Table 3.

Measurement of parameters of glycaemic variability in PPH patients.

		Symptomatic PPH (N = 11)
GV measure	Reference range	Awake (06:00–22:00)	Asleep (22:00–06:00)	Total
s.d.	0.0–3.0	1.8 ± 0.7**	1.2 ± 0.1	1.8 ± 0.2
CONGA	3.6–5.5	4.8 ± 0.1***	4.2 ± 0.1	4.6 ± 0.2
LI	0.0–4.7	5.1 ± 0.6**	3.1 ± 0.7	4.7 ± 0.8
J-INDEX	4.7–23.6	18.8 ± 1.2***	13.8 ± 1.1	18.4 ± 1.9
LBGI	0.0–6.9	3.8 ± 0.7**	5.4 ± 0.8	4.9 ± 1.1
HBGI	0.0–7.7	3.5 ± 0.5**	1.8 ± 0.4	3.4 ± 0.7
GRADE	0.0–4.6	2.2 ± 0.9	1.8 ± 0.4	1.2 ± 0.2
MODD	0.0–3.5	N/A	N/A	1.5 ± 0.1
MAGE	0.0–2.8	5.0 ± 0.4***	2.6 ± 0.3	4.9 ± 0.4
ADDR	0.0–8.7	N/A	N/A	12.0 ± 2.9
M Value	0.0–12.5	6.7 ± 1.5*	10.1 ± 2.6	9.4 ± 2.7
MAG	0.5–2.2	2.3 ± 0.1*	1.8 ± 0.1	2.3 ± 0.2
% time in hypoglycemia <3.0		2.4 ± 1.4	1.7 ± 1.1	2.0 ± 0.9
% time in range, 3.0–7.0		76.0 ± 4.0	86.8 ± 2.7	81.4 ± 2.6
% time in hyperglycemia >7.0		21.6 ± 3.7	11.6 ± 2.8	16.6 ± 2.5

^*P value <0.01, **P value <0.001 and ***P value <0.0001.

ADRR, average daily risk ratio; CONGA, continuous overlapping net glycaemic action; GRADE, glycaemic risk assessment in diabetes equation; HBGI, high blood glucose index; LBGI, low blood glucose index; LI, lability index; MAG, mean absolute glucose; MAGE, Mean Amplitude Glucose Excursion; MODD, mean of daily differences; s.d., standard deviation.